![]() |
|
|

-Methylene ATP-Sensitive Phenotype
Glaxo Institute of Applied Pharmacology, Cambridge, United Kingdom (C.A.J., L.A.S., P.P.A.H., I.P.C.); and Department of Cell Physiology and Pharmacology, University of Leicester, Leicester, United Kingdom (C.V., R.J.E.)
Investigation of rat recombinant P2X6 receptors has been limited because of the difficulty in obtaining functional expression in heterologous systems. In this study, we demonstrate glycosylation-dependent regulation of recombinant P2X6 receptor function and associated conferral of a novel phenotype that is sensitive to the P2X1 and P2X3 receptor agonist, 
-methylene ATP. In cells functionally expressing P2X6 receptors, ATP and 
-methylene ATP evoked slowly desensitizing inward currents (EC50 values, 0.5 and 0.6 µM, respectively) with slow kinetics of current decay on agonist washout. 2',3'-O-(2,4,6-trinitrophenyl ATP) and iso-pyridoxalphosphate-6-azophenyl-2'-5'-disulfonate were effective antagonists (IC50 values, 0.8 and 22 µM, respectively); however, suramin was relatively ineffective. Reverse transcription-polymerase chain reaction analysis confirmed the absence of other P2X receptor subunits. Western analysis of membrane fractions from functional and nonfunctional clones confirmed the presence of P2X6 at the cell membrane but revealed a difference in apparent molecular mass of immunoreactive products (
70 and
60 kDa, respectively). N-glycosidase F treatment of both functional and nonfunctional receptor cell membranes increased the electrophoretic mobilities of immunoreactive products, with both proteins migrating at
55 kDa, demonstrating an increased level of glycosylation of the P2X6 receptor in functional compared with nonfunctional cells. This study demonstrates that nonfunctional rat recombinant P2X6 receptors 1) are expressed on the membrane surface of human embryonic kidney cells and 2) are glycosylated. Expression of the novel functional receptor phenotype is associated with further glycosylation, resulting in an apparently larger molecular mass. These results suggest that P2X6 receptor subunits contribute to 
-methylene ATP sensitivity.
Address correspondence to: Iain Chessell, Neurology CEDD, GlaxoSmithKline, New Frontiers Science Park-North, Coldharbour Road, The Pinnacles, Harlow, Essex CM19 5AW, UK. E-mail: iain.p.chessell{at}gsk.com
This article has been cited by other articles:
![]() |
Y. Zhang, D. Sanchez, J. Gorelik, D. Klenerman, M. Lab, C. Edwards, and Y. Korchev Basolateral P2X4-like receptors regulate the extracellular ATP-stimulated epithelial Na+ channel activity in renal epithelia Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1734 - F1740. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Lorier, A. G. Huxtable, D. M. Robinson, J. Lipski, G. D. Housley, and G. D. Funk P2Y1 Receptor Modulation of the Pre-Botzinger Complex Inspiratory Rhythm Generating Network In Vitro J. Neurosci., January 31, 2007; 27(5): 993 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. da Silva, R. R. Resende, and H. Ulrich Genomic Physiology: Alternative splicing of P2X6 receptors in developing mouse brain and during in vitro neuronal differentiation Exp Physiol, January 1, 2007; 92(1): 139 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Ormond, N. P. Barrera, O. S. Qureshi, R. M. Henderson, J. M. Edwardson, and R. D. Murrell-Lagnado An Uncharged Region within the N Terminus of the P2X6 Receptor Inhibits Its Assembly and Exit from the Endoplasmic Reticulum Mol. Pharmacol., May 1, 2006; 69(5): 1692 - 1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ma, A. Korngreen, S. Weil, E. B.-T. Cohen, A. Priel, L. Kuzin, and S. D. Silberberg Pore properties and pharmacological features of the P2X receptor channel in airway ciliated cells J. Physiol., March 15, 2006; 571(3): 503 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kennedy P2X Receptors: Targets for Novel Analgesics? Neuroscientist, August 1, 2005; 11(4): 345 - 356. [Abstract] [PDF] |
||||
![]() |
L. Liang, A. Zsembery, and E. M. Schwiebert RNA interference targeted to multiple P2X receptor subtypes attenuates zinc-induced calcium entry Am J Physiol Cell Physiol, August 1, 2005; 289(2): C388 - C396. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Barrera, S. J. Ormond, R. M. Henderson, R. D. Murrell-Lagnado, and J. M. Edwardson Atomic Force Microscopy Imaging Demonstrates that P2X2 Receptors Are Trimers but That P2X6 Receptor Subunits Do Not Oligomerize J. Biol. Chem., March 18, 2005; 280(11): 10759 - 10765. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liang and E. M. Schwiebert Large pore formation uniquely associated with P2X7 purinergic receptor channels. Focus on "Are second messengers crucial for opening the pore associated with P2X7 receptor?" Am J Physiol Cell Physiol, February 1, 2005; 288(2): C240 - C242. [Full Text] [PDF] |
||||
![]() |
L. Wang, Y.-H. Feng, and G. I. Gorodeski Epidermal Growth Factor Facilitates Epinephrine Inhibition of P2X7-Receptor-Mediated Pore Formation and Apoptosis: A Novel Signaling Network Endocrinology, January 1, 2005; 146(1): 164 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
Kelvin. C. Agboh, T. E. Webb, R. J. Evans, and S. J. Ennion Functional Characterization of a P2X Receptor from Schistosoma mansoni J. Biol. Chem., October 1, 2004; 279(40): 41650 - 41657. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Watano, J. A. Calvert, C. Vial, I. D. Forsythe, and R. J. Evans P2X receptor subtype-specific modulation of excitatory and inhibitory synaptic inputs in the rat brainstem J. Physiol., August 1, 2004; 558(3): 745 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chaumont, L.-H. Jiang, A. Penna, R. A. North, and F. Rassendren Identification of a Trafficking Motif Involved in the Stabilization and Polarization of P2X Receptors J. Biol. Chem., July 9, 2004; 279(28): 29628 - 29638. [Abstract] [Full Text] [PDF] |
||||